Sunday, April 11, 2021

China's Sinovac Cuts Risk Of Symptomatic Covid But 50% Effective: Study

Sinovac Biotech Ltd.'s coronavirus vaccine cut in half the risk of developing symptomatic Covid-19 in a key Brazilian study, suggesting two doses of the shot is less potent than some other...

from NDTV News - Latest https://ift.tt/3d5VAV8
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

"Rampant Favouritism": Reddit User Calls NRI Managers "Worse" Than Indian Bosses

According to the post, these managers tend to treat Indian team members as subordinates and reserve high-profile projects for a select few, ...